Power and sample size calculations for case-control studies of gene- environment interactions with a polytomous exposure variable

American Journal of Epidemiology

Volumn 146, Issue 7, 1997, Pages 596-604

  Foppa, Ivo ^a   Spiegelman, Donna ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Case control studies; Epidemiologic methods; Epidemiology, molecular; Interaction; Sample size; Statistical power; Statistics; Study design

Indexed keywords

ARTICLE; CALCULATION; CASE CONTROL STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENE FREQUENCY; GENETIC POLYMORPHISM; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0031472899     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009320     Document Type: Article

References (14)

1. Hwang S-J, Beaty TH, Liang K-Y, et al. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol 1994;140:1029-37.
2. Rosner B. Fundamentals of biostatistics. Belmont, MA: Duxbury Press, 1994.
3. Agresti A. Categorical data analysis. New York, NY: John Wiley & Sons, 1990.
4. Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984;13:356-65.
5. Zhong S, Wyllie AH, Barnes D, et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14: 1821-24.
6. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabloism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
7. Vineis P, Bartsch H, Caparaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcionogens. Nature 1994;369: 154-6.
8. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86:712-16.
9. Cartwright RA, Glashan RW, Rogers HJ, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemioloigcal approach to bladder cancer. Lancet 1982;2:842-5.
10. Peto J, Easton DF, Matthews FE, et al. Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 1996;65:275-83.
11. Greenland S. Tests for interaction in epidemiological studies: a review and a study of power. Stat Med 1983;2:243-51.
12. Lubin JH, Gail MH. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol 1990;131:552-66.
13. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York, NY: Oxford University Press, 1993:164-99.
14. Prentice RC, Pyke R. Logistic disease incidence models and case-control studies. Biometrika 1979;66:403-12.